newsfilter
← Latest News
GlobeNewswire·

Eargo Applauds Proposed Rule for OTC Hearing Aids and Submits Public Comments to FDA

SAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ:EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the submission of public comments to the Food and Drug Admin